Mednax Inc (MD)
Gross profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 2,012,920 | 421,565 | 467,033 | 513,242 | 449,321 |
| Revenue | US$ in thousands | 2,012,920 | 1,994,640 | 1,972,020 | 1,911,190 | 1,733,950 |
| Gross profit margin | 100.00% | 21.13% | 23.68% | 26.85% | 25.91% |
December 31, 2024 calculation
Gross profit margin = Gross profit ÷ Revenue
= $2,012,920K ÷ $2,012,920K
= 100.00%
The gross profit margin of Mednax Inc has displayed varying trends over the past five years. In December 2020, the gross profit margin stood at 25.91%, showing a moderate level of profitability. Subsequently, there was an improvement in December 2021 as the margin increased to 26.85%, indicating better cost management or pricing strategies.
However, there was a notable decline in profitability by December 2022, with the gross profit margin dropping to 23.68%. This decrease might suggest challenges in controlling production costs or pressure from pricing competition within the industry.
Further, by December 2023, the gross profit margin fell notably to 21.13%, indicating a continued struggle with maintaining profitability. It's essential for the company to assess and address the factors contributing to this decline to sustain long-term financial health.
Remarkably, in December 2024, the gross profit margin skyrocketed to 100.00%, which seems unusual and may be due to one-time events, accounting adjustments, or data anomalies that need to be carefully investigated and verified. Overall, consistent monitoring and analysis of the gross profit margin trends are crucial for understanding Mednax Inc's financial performance and making informed strategic decisions.
Peer comparison
Dec 31, 2024